Breaking News

The Power of Innovation: How New Technologies are Changing the Fight Against TB

“Cards for Sharing”: Black & White Ginger Ale and Virtue India’s Vision for a More Inclusive World

FedEx Express Pushes the Boundaries of Healthcare Logistics at Great Indian Biologics Festival 2023

Emmes Acquires Essex Management to Enhance Clinical Research Services

Cancer Research UK-backed trial finds chemotherapy before surgery reduces risk of colon cancer recurrence

RCDS Goes Green and Empowers Leprosy Patients with Solar Power Plant and Relief Aid

Smile Train Celebrates Momentous Milestone: 700,000 Cleft Surgeries in India

ENTOD Eye Health Foundation Raises Awareness About Glaucoma with Innovative Campaign

ChickP’s Chickpea Isolate Revolutionizes the Plant-Based Cheese Industry

Nutrizoe Launches Zoe Bars: Delicious, Nutritious Energy Bars Designed Specifically for Women

Emmes Acquires Essex Management to Enhance Clinical Research Services

Emmes, a leading Clinical Research Organization (CRO) focused on advancing public health and biopharmaceutical innovation, has acquired Essex Management, a company that offers bioinformatics and health information technology (HIT) consulting services to various organizations. This acquisition is part of Emmes’ ongoing growth strategy, which involves expanding its services through complementary acquisitions and organic growth. With […]

News ReportMarch 23, 2023

Glenmark Pharmaceuticals granted FDA acceptance to proceed with clinical trial of GRC 54276 for advanced solid tumors and lymphomas

Glenmark Pharmaceuticals, a global innovation-driven pharmaceuticals company, has announced that the US Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for GRC 54276. The company plans to proceed with a Phase 1/2 clinical study of GRC 54276 in patients with advanced solid tumors and lymphomas. GRC 54276 is an orally […]

News ReportMarch 17, 2023

Revolutionary Mi-Helper Device to Undergo Decentralized Clinical Trial for Migraine Treatment

Mi-Helper, Inc. has partnered with ObvioHealth to conduct a groundbreaking decentralized clinical trial for their non-invasive neuromodulation device for the treatment of migraines. The randomized controlled trial will be fully remote, allowing patients to use the device from home, providing a real-world population with essential data in a real-world setting. Migraines affect one billion people […]

News ReportMarch 17, 2023

Josh Foundation Organizes “Josh Super League,” a Sports Event for Hearing-Impaired Kids

The Josh Foundation recently hosted the “Josh Super League,” a sports event aimed at promoting values like an active lifestyle and team building among hearing-impaired children. The event was held on World Hearing Day and saw the participation of around 325 hearing-impaired children competing against each other in yoga, athletics, cricket, basketball, and football. The […]

News ReportMarch 10, 2023
Pharma Updates

Cancer Research UK-backed trial finds chemotherapy before surgery reduces risk of colon cancer recurrence

Colon cancer patients can significantly reduce their risk of cancer returning by receiving chemotherapy before surgery, according to a clinical trial funded by Cancer Research UK. The FOxTROT trial, led by scientists from the University of Birmingham and the University of Leeds, involved 1,053 colon cancer patients from 85 hospitals in the UK, Denmark, and […]

News Report

Clear Within partners with DolCas Biotech to launch enhanced beauty-from-within supplement

Clear Within, a popular nutritional supplement company, has teamed up with DolCas Biotech to create a revolutionary vegan nutricosmetic product for achieving clear, glowing skin from within. The key ingredient selected by Clear Within for its reformulated beauty-from-within supplement is DolCas Biotech’s Curcugen® turmeric extract. Turmeric extracts are becoming increasingly popular in nutritional supplements, and […]

News Report

Eli Lilly Brings Relief to Psoriasis and Psoriatic Arthritis Sufferers with Copellor® Launch in India

Eli Lilly, the global pharmaceutical company, has announced the launch of Copellor® (Ixekizumab) in India, a drug designed to provide relief to adults with moderate-to-severe plaque psoriasis and psoriatic arthritis. Copellor® (Ixekizumab) is a humanized IgG4 monoclonal antibody that targets the IL-17A protein responsible for inflammation in psoriasis. The Drug Controller General of India (DCGI) […]

News Report
Load More Posts